Am J Transplant, Volume 19, Suppl 3 Archives - Page 26 of 214 - ATC Abstracts

2019 American Transplant Congress
CURATE.AI: Personalized Liver Transplant Tacrolimus Dosing
A. Zarrinpar¹, T. Kee², P. Wang³, J. Khong³, U. Kim¹, J. Chong², J. B. Jeong³, A. T. Truong², S. Tan², B. K. Betzler², W. Ng², C. Ho³, D. Ho²
¹Surgery, University of Florida, Gainesville, FL, ²National University of Singapore, Singapore, Singapore, ³UCLA, Los Angeles, CA
*Purpose: Transplant immunosuppressive regimens include multiple drugs with varying pharmacokinetics, metabolic pathways, and drug-drug interactions. This study aimed to use CURATE.AI, an artificial intelligence platform,…
2019 American Transplant Congress
Lower Alcohol Taxes Are Associated with Increased Liver Transplant Listing
N. T. Shen¹, M. Raver¹, N. Hutchison¹, A. Jesudian¹, J. Bray², B. Schackman³, R. S. Brown¹
¹Medicine; Division of Gastroenterology and Hepatology, New York Presbyterian Hospital - Weill Cornell, New York, NY, ²Economics, University of North Carolina at Greensboro, Greensboro, NC, Greensboro, NC, ³Healthcare Policy and Research, Weill Cornell Medicine, New York, NY
*Purpose: Alcoholic liver disease (ALD) is a leading indication for liver transplantation worldwide with rising prevalence. Whether relationships exist between transplant listing for ALD and…
2019 American Transplant Congress
Redox State of HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation
R. A. Sosa¹, A. Q. Terry¹, J. Nevarez-Mejia¹, M. Rossetti¹, B. V. Naini¹, V. M. Groysberg¹, F. M. Kaldas², R. W. Busuttil², D. W. Gjertson¹, J. W. Kupiec-Weglinski², E. F. Reed¹
¹Pathology & Laboratory Medicine, UCLA, Los Angeles, CA, ²Surgery, UCLA, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) is a major risk factor of acute and chronic graft rejection in orthotopic liver transplantation (OLT) involving a complex interplay between…
2019 American Transplant Congress
Obese Simultaneous Pancreas And Kidney Transplant Recipients In Type 2 Diabetes Have Similar Risks Of Pancreas Failure As Non-obese
T. Alhamad¹, K. Espinoza¹, J. R. Wellen¹, S. Chang¹, D. C. Brennan², K. L. Lentine³
¹Washinton University in St. Louis, St. Louis, MO, ²Johns Hopkins University, Baltimore, MD, ³Saint Louis University, St. Louis, MO
*Purpose: In October 2014, United Network for Organ Sharing (UNOS) implemented criteria for simultaneous pancreas and kidney transplant (SPKT) in patients with c-peptide 2 >…
2019 American Transplant Congress
Pancreas Allograft Importation Should Be Fostered by Any Transplant Center Challenged by Excessively Long Waitlist Times
J. Torabi, J. P. Rocca, L. Lirano, Y. Azzizi, M. Ajaimy, C. Pynadath, E. Akalin, M. Kinkhabwala, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Pancreas transplantation is a durable option for patients with insulin dependent diabetes. However, geographic inequity has created a supply side problem for our region.…
2019 American Transplant Congress
Pre-Operative C-Peptide Predicts Weight Gain after Pancreas Transplantation
J. Torabi, J. P. Rocca, E. Kestenbaum, M. Ajaimy, M. Kinkhabwala, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Transplant recipients are susceptible to metabolic syndrome as typified by hyperglycemia, central obesity and increased insulin resistance after transplant, which may precede the onset…
2019 American Transplant Congress
Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients, Barriers and Predictors
S. Taj¹, H. Baghaffar², D. Alnajjar², N. Almashabi³, S. Ismail⁴
¹King Saud Bin Abdulaziz University For Health Sciences, Jeddah, Saudi Arabia, ²Ibn Sina College, Jeddah, Saudi Arabia, ³Umm Al-Qura University, Makkah, Saudi Arabia, ⁴Pharmaceutical Care Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia
*Purpose: Non-adherence to immunosuppressant therapy (IST) is one of the major factors leading to graft rejection. To our knowledge, limited data exist on the prevalence…
2019 American Transplant Congress
Racial Differences in Cancer Mortality for Kidney Transplant Recipients
K. Cordrey, J. Motter, A. Kernodle, K. Jackson, M. Camp, T. Purnell, D. Segev, J. Garonzik Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Cancer is the second leading cause of post-transplant mortality. Since racial disparities have been reported in many aspects of transplant care, we sought to…
2019 American Transplant Congress
Long Term Follow-Up of the Use of Checkpoint Inhibitors in Kidney Transplant Recipients
K. Venkatachalam, R. Delos Santos, T. Alhamad
Transplant nephrology, Washington University, St. Louis, MO
*Purpose: To report the long term impact of check point inhibitors in patient and allograft survival among kidney transplant recipients.*Methods: We report follow up of…
2019 American Transplant Congress
EBV+ PTLD in the Modern Immunosuppression Era: Role of EBV Serology and DNAemia-Preliminary Data from CTOT-C06
O. M. Martinez¹, S. M. Krams¹, M. A. Robien², M. Lapasaran¹, S. D. Boyd¹, B. Armstrong³, C. Twist⁴, K. Weinberg¹, D. Gratzinger¹, B. Tan¹, M. Sever³, D. Ikle³, M. Brown², D. Bernstein¹, C. O. Esquivel¹
¹Stanford University Sch of Med, Stanford, CA, ²NIAID/NIH, Rockville, MD, ³Rho, Chapel Hill, NC, ⁴Roswell Park, Buffalo, NY
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) remains a serious problem in the pediatric transplant population. The Clinical Trials of Organ Transplantation in Children (CTOT-C)-06 is an…